CRIL and CRB back SpiroGen
Cambridge Research BioVentures (CRB) and Cambridge Research and Innovation Ltd (CRIL) have led a £1m investment in Spirogen, which develops gene technology.
Cambridge Research BioVentures (CRB) and Cambridge Research and Innovation Ltd (CRIL) have led a £1m investment in Spirogen, which develops gene technology.
Copyright PEI Media
Not for publication, email or dissemination